Related Experiment Video
Updated: Jan 10, 2026

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.8K
Iron addicted colorectal cancers exploit Heme-Complex II axis to resist oxidative cell death
Biorxiv : the Preprint Server for Biology
|November 24, 2025
Summary
Colorectal cancer cells exploit iron for growth but can die from iron overload. A novel heme-succinate dehydrogenase (SDH)-Coenzyme Q (CoQ) pathway helps these cells survive toxic iron levels by detoxifying oxidative stress.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Colorectal cancer (CRC) cells exhibit high iron dependency for proliferation.
- High intracellular iron is generally cytotoxic, posing a question about CRC cell survival in iron-rich environments.
- Ferroptosis, an iron-dependent cell death, is a known pathway, but its role in iron-induced cell death in CRC in vivo is not fully understood.
Purpose of the Study:
- To investigate the mechanisms by which colorectal cancer cells tolerate and exploit iron-rich environments.
- To identify novel pathways involved in buffering iron-induced oxidative stress in CRC.
- To explore the role of the heme-succinate dehydrogenase (SDH)-Coenzyme Q (CoQ) axis in CRC cell survival.
Main Methods:
- Multi-omics profiling
- CRISPR screening
- In vivo mouse models
- Biochemical assays
Main Results:
- A novel heme-dependent succinate dehydrogenase (SDH)-Coenzyme Q (CoQ) axis was identified in CRC cells.
- This axis enables CRC cells to buffer iron-induced oxidative stress by reducing CoQ.
- Reduced CoQ acts as a radical-trapping antioxidant, detoxifying lipid reactive oxygen species (ROS) at mitochondrial and plasma membranes.
- This pathway operates independently of, or in parallel with, canonical ferroptosis regulators.
Conclusions:
- Colorectal cancer cells co-opt metabolic pathways, including the SDH-CoQ axis, for survival under toxic iron conditions.
- This heme-SDH-CoQ pathway is crucial for detoxifying iron-induced oxidative stress in CRC.
- The findings reveal new therapeutic vulnerabilities in colorectal cancer related to iron metabolism and oxidative stress management.
Related Concept Videos
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Electron Transport Chain: Complex III and IV
9.0K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.0K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
The Electron Transport Chain
19.6K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
19.6K

